Geriatricians, general internists, and potentially inappropriate medications for a national sample of older adults
Journal of the American Geriatrics Society · 2024
DOI: 10.1111/jgs.18489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2024. Verfasst von Jonathan L Vandergrift und 3 weiteren Autor:innen. Beteiligte Einrichtung: Assessment and Research, American Board of Internal Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Potentially Inappropriate Medication List, Physicians. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Older adults are often prescribed medications that are potentially dangerous and geriatricians have specialized training in treating polypharmacy that may benefit these patients. To examine this, we compared potentially inappropriate medication (PIM) prescribing rates between geriatricians and similar general internists in the United States.
Methods
Using national cross‐sectional data from 2013 to 2019, we compared annual PIM prescribing rates between 2815 outpatient geriatricians certified by the American Board of Internal Medicine in 1994–2018 and general internists matched 1:1 on IM certification exam score and year, residency exam pass rate, gender, and US birth and/or US medical school. PIM prescribing was based on the Healthcare Effectiveness Data and Information Set (HEDIS) PIM physician annual prescribing measures which consider medications flagged as potentially inappropriate in the American Geriatric Society Beers Criteria® guideline. We also examined prescribing of appropriate alternative medications. Prescribing rates were calculated as the percentage a physician's patients with Medicare fee‐for‐service part D enrollment seen in the outpatient setting in a given year (mean: 150 patients per physician) with a PIM prescription they prescribed.
Results
Across 30,677 physician‐year observations, geriatricians were 16.7% less likely (95% confidence interval (CI): −19.8 to −13.7, p < 0.001) to prescribe a PIM (7.2% versus 8.7% of patients respectively) and 2.7% more likely (95% CI: 0.8 to 4.5, p = 0.004) to prescribe an appropriate alternative medication (52.0% versus 50.7% of patients respectively). Lower PIM prescribing was observed for most medication sub‐types including central nervous system, anticholinergic, pain, and endocrine medications. In sensitivity analyses, differences in prescribing were similar when comparing recently trained physicians with more experienced physicians.
Conclusion
Findings suggest geriatricians in the United States prescribe PIMs at lower rates than general internists. This highlights the value geriatricians provide as well as opportunities to embed key principles of geriatric care into internal medicine training and health care delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Assessment and Research, American Board of Internal Medicine, Philadelphia, Pennsylvania, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Jonathan L Vandergrift
Zitieren
APA
Vandergrift, J. L., Weng, W., Leff, B., & Gray, B. M. (2024). Geriatricians, general internists, and potentially inappropriate medications for a national sample of older adults. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.18489
Vancouver
Vandergrift JL, Weng W, Leff B, Gray BM. Geriatricians, general internists, and potentially inappropriate medications for a national sample of older adults. Journal of the American Geriatrics Society. 2024. doi:10.1111/jgs.18489
BibTeX
@article{Vandergrift2024,
author = {Vandergrift, Jonathan L and Weng, Weifeng and Leff, Bruce and Gray, Bradley M},
title = {Geriatricians, general internists, and potentially inappropriate medications for a national sample of older adults},
journal = {Journal of the American Geriatrics Society},
year = {2024},
doi = {10.1111/jgs.18489}
}
EUVIMED